Evidence map›Paper›PMID 42188869›Full record

ArticleTropical medicine and infectious disease2026

Unveiling Clinical Phenotypes in Chronic Chikungunya Disease: Insights from a Brazilian Observational Study.

Karen Santos Lima, Adriane Paz Rocha, Alice Lanna Damásio Castro, Anna Carolina Faria Moreira Gomes Tavares, Flávia Patrícia Sena Teixeira Santos, Gilda Aparecida Ferrreira, Livia Barbara Cordeiro Alves, Josiane Lino Dos Santos Frattari, Juliana Froeseler Fittipaldi, Lucas Borba Paulino Coelho and 6 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Karen Santos LimaHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Adriane Paz RochaHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Alice Lanna Damásio CastroUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.
Anna Carolina Faria Moreira Gomes TavaresHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.ORCID 0000-0002-1920-1115
Flávia Patrícia Sena Teixeira SantosHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Gilda Aparecida FerrreiraDepartamento do Aparelho Locomotor, Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Livia Barbara Cordeiro AlvesUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.
Josiane Lino Dos Santos FrattariUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.
Juliana Froeseler FittipaldiUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.
Lucas Borba Paulino CoelhoUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.
Maria Fernanda Brandão de Resende GuimarãesHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.ORCID 0000-0003-3865-3739
Pedro Ribeiro de Jesus AlmeidaUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.ORCID 0000-0003-0708-7797
Último Libânio CostaUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.ORCID 0000-0003-3666-5314
Cristina Costa Duarte LannaDepartamento do Aparelho Locomotor, Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Gustavo Gomes ResendeHospital das Clínicas, Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 110, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
Mauro Martins TeixeiraUnidade de Pesquisa Clínica, Centro de Terapias Avançadas e Inovadoras, Universidade Federal de Minas Gerais, Rua Carlos Pinheiro Chagas, 20, Jardim Montanhês, Belo Horizonte 30750-150, MG, Brazil.ORCID 0000-0002-6944-3008

Funding

Instituto Nacional de Ciência e Tecnologia em Dengue e Internação microorganismo-hospedeiro 465425/2014-3
6 · The paper itself

Abstract

Chronic chikungunya disease (CCD) affects approximately 30-50% of infected individuals and is associated with persistent inflammatory arthritis, chronic pain, and long-term functional disability. We conducted a prospective observational cohort study including 584 patients with laboratory-confirmed chikungunya infection, evaluated between 3 and 12 months after acute infection, to better understand the natural history, risk factors, clinical presentation, and treatment patterns of CCD. Here, we present a cross-sectional analysis derived from this cohort. Older age, female sex, and higher body mass index were identified as major risk factors for CCD. Four distinct clinical phenotypes were identified: Axial (12.2%), defined by inflammatory axial pain regardless of peripheral manifestations; Oligoarthritis (18.1%), defined by fewer than four swollen joints; Polyarthritis (10.6%), defined by four or more swollen joints; and Pain without Swelling (70.4%), characterized by myalgia and/or arthralgia in the absence of objective inflammatory findings on physical examination. The axial phenotype could overlap with peripheral phenotypes, whereas oligoarthritis, polyarthritis, and pain without swelling were mutually exclusive categories. These phenotypes differed substantially in symptom burden and clinical impact. Patients with the Pain without Swelling phenotype had longer symptom duration, whereas Axial and Polyarthritis phenotypes were associated with greater functional impairment and higher disease burden. These findings reinforce the clinical heterogeneity of CCD and support the potential value of phenotype-based approaches for clinical management and future therapeutic research.

Indexed as

axialchikungunya feveroligoarthritisphenotypespolyarthritis

Identifiers

PMID42188869
PMCPMC13211594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.